These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7924138)

  • 1. Molecular basis of osteogenesis imperfecta and related disorders of bone.
    Prockop DJ; Kuivaniemi H; Tromp G
    Clin Plast Surg; 1994 Jul; 21(3):407-13. PubMed ID: 7924138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in type 1 procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies.
    Prockop DJ; Colige A; Helminen H; Khillan JS; Pereira R; Vandenberg P
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S489-92. PubMed ID: 8122517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone fragility in transgenic mice expressing a mutated gene for type I procollagen (COL1A1) parallels the age-dependent phenotype of human osteogenesis imperfecta.
    Pereira RF; Hume EL; Halford KW; Prockop DJ
    J Bone Miner Res; 1995 Dec; 10(12):1837-43. PubMed ID: 8619363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue.
    Prockop DJ; Constantinou CD; Dombrowski KE; Hojima Y; Kadler KE; Kuivaniemi H; Tromp G; Vogel BE
    Am J Med Genet; 1989 Sep; 34(1):60-7. PubMed ID: 2683782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular heterogeneity in osteogenesis imperfecta type I.
    Willing MC; Pruchno CJ; Byers PH
    Am J Med Genet; 1993 Jan; 45(2):223-7. PubMed ID: 8456806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the COL1A2 gene of type I collagen that result in nonlethal forms of osteogenesis imperfecta.
    Wenstrup RJ; Lever LW; Phillips CL; Quarles LD
    Am J Med Genet; 1993 Jan; 45(2):228-32. PubMed ID: 8456807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene.
    Stacey A; Bateman J; Choi T; Mascara T; Cole W; Jaenisch R
    Nature; 1988 Mar; 332(6160):131-6. PubMed ID: 2450280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteogenesis imperfecta: prospects for molecular therapeutics.
    Forlino A; Marini JC
    Mol Genet Metab; 2000; 71(1-2):225-32. PubMed ID: 11001814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
    Gajko-Galicka A
    Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
    Ries-Levavi L; Ish-Shalom T; Frydman M; Lev D; Cohen S; Barkai G; Goldman B; Byers P; Friedman E
    Hum Mutat; 2004 Apr; 23(4):399-400. PubMed ID: 15024745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of a G nucleotide deletion in the Cola-2 gene of mice with the osteogenesis imperfecta mutation.
    McBride DJ; Shapiro JR
    Genomics; 1994 Mar; 20(1):135-7. PubMed ID: 8020944
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteogenesis imperfecta at the beginning of bone and joint decade.
    Primorac D; Rowe DW; Mottes M; Barisić I; Anticević D; Mirandola S; Gomez Lira M; Kalajzić I; Kusec V; Glorieux FH
    Croat Med J; 2001 Aug; 42(4):393-415. PubMed ID: 11471191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligodeoxynucleotides selectively suppress expression of the mutant alpha 2(I) collagen allele in type IV osteogenesis imperfecta fibroblasts. A molecular approach to therapeutics of dominant negative disorders.
    Wang Q; Marini JC
    J Clin Invest; 1996 Jan; 97(2):448-54. PubMed ID: 8567966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two new recurrent nucleotide mutations in the COL1A1 gene in four patients with osteogenesis imperfecta: about one-fifth are recurrent.
    Körkkö J; Kuivaniemi H; Paassilta P; Zhuang J; Tromp G; DePaepe A; Prockop DJ; Ala-Kokko L
    Hum Mutat; 1997; 9(2):148-56. PubMed ID: 9067755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COL1A1 mutation analysis in Lithuanian patients with osteogenesis imperfecta.
    Benusiené E; Kucinskas V
    J Appl Genet; 2003; 44(1):95-102. PubMed ID: 12590186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.
    Hartikka H; Kuurila K; Körkkö J; Kaitila I; Grénman R; Pynnönen S; Hyland JC; Ala-Kokko L
    Hum Mutat; 2004 Aug; 24(2):147-54. PubMed ID: 15241796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.
    Xia XY; Cui YX; Huang YF; Pan LJ; Yang B; Wang HY; Li XJ; Shi YC; Lu HY; Zhou YC
    Clin Chim Acta; 2008 Dec; 398(1-2):148-51. PubMed ID: 18755172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV.
    Ward LM; Lalic L; Roughley PJ; Glorieux FH
    Hum Mutat; 2001 May; 17(5):434. PubMed ID: 11317364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen.
    Wenstrup RJ; Tsipouras P; Byers PH
    J Clin Invest; 1986 Dec; 78(6):1449-55. PubMed ID: 3782466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular findings in Brazilian patients with osteogenesis imperfecta.
    Reis FC; Alexandrino F; Steiner CE; Norato DY; Cavalcanti DP; Sartorato EL
    J Appl Genet; 2005; 46(1):105-8. PubMed ID: 15741671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.